Generative artificial intelligence (GenAI) models, such as generative adversarial networks (GANs) and transformer-based large language models (LLMs), are developing at an accelerated pace and positioned to be integrated into clinical workflows and healthcare systems across the world. However, this rapid rise of GenAI in medicine and healthcare presents not just unprecedented opportunities, but also systemic risks in the integration of this new technology and critical vulnerabilities in terms of safety, governance and regulatory oversight. GenAI and LLMs are non-deterministic in nature, possess broad generalist functionalities, and display evolving capabilities. These characteristics challenge conventional regulatory frameworks designed for deterministic, task-specific artificial intelligence (AI) models, such as those for Software as a Medical Device (SaMD).
Publications • June 30, 2025
International partnership for governing generative artificial intelligence models in medicine
By Various Authors
Share
-
linkedin -
facebook -
twitter
More about: Mission Control Center, AI Platform, Artificial Intelligence.
Publications • July 10, 2024
A Call for Artificial Intelligence Implementation Science Centers to Evaluate Clinical Effectiveness
By Karandeep Singh, MD
Publications • June 18, 2024
The Chief Health AI Officer — An Emerging Role for an Emerging Technology
By Ashley N Beecy, MD & Karandeep Singh, MD
Publications • January 23, 2024
Impact of a deep learning sepsis prediction model on quality of care and survival
By Aaron Boussina, PhD & Supreeth P. Shashikumar, PhD